Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 28323831)

Published in PLoS Med on March 21, 2017

Authors

R Desikan1, Chun Chieh Fan2, Yunpeng Wang3,4,5, Andrew J Schork2, Howard J Cabral6, L Adrienne Cupples6, Wesley K Thompson7, Lilah Besser8, Walter A Kukull8, Dominic Holland3, Chi-Hua Chen9, James B Brewer3,9,10, David S Karow9, Karolina Kauppi9, Aree Witoelar4,5, Celeste M Karch11, Luke W Bonham12, Jennifer S Yokoyama13, Howard J Rosen12, Bruce L Miller12, William P Dillon14, David M Wilson14, C P Hess1, Margaret Pericak-Vance15, Jonathan L Haines16,17, Lindsay A Farrer18,19,20,6,21, Richard Mayeux22,23,24, John Hardy25, Alison M Goate26,27, Bradley T Hyman28, Gerard D Schellenberg29, Linda K McEvoy9, Ole A Andreassen4,5, Anders M Dale2,3,9

Author Affiliations

1: From the Departments of Radiology and Biomedical Imaging (J.C., O.T., R.D., T.F., H.K., C.P.H., A.J.B., D.X.) and Pediatrics and Neurology (D.G., D.M.F.), University of California, San Francisco, San Francisco, California.
2: Department of Cognitive Science, University of California, San Diego, La Jolla, California, United States of America.
3: Department of Neurosciences, University of California, San Diego, La Jolla, California, United States of America.
4: Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
5: Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
6: Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
7: Institute for Biological Psychiatry, Sankt Hans Psychiatric Hospital, Roskilde, Denmark.
8: National Alzheimer's Coordinating Center, Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
9: Department of Radiology, University of California, San Diego, La Jolla, California, United States of America.
10: Shiley-Marcos Alzheimer's Disease Research Center, University of California, San Diego, La Jolla, California, United States of America.
11: Department of Psychiatry and Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110;
12: Department of Neurology, University of California, San Francisco, California, United States of America.
13: Department of Neurology, University of California, San Francisco, San Francisco, California, United States of America.
14: Neuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, United States of America.
15: John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States of America.
16: Department of Epidemiology and Biostatistics, Case Western University, Cleveland, Ohio, United States of America.
17: Institute for Computational Biology, Case Western University, Cleveland, Ohio, United States of America.
18: Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts, United States of America.
19: Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
20: Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
21: Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America.
22: Department of Neurology, Columbia University, New York, New York, United States of America.
23: Taub Institute on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America.
24: Gertrude H. Sergievsky Center, Columbia University, New York, New York, United States of America.
25: Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom.
26: Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
27: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
28: Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
29: Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.

Articles cited by this

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA (1997) 17.88

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health (1998) 9.58

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res (2007) 8.48

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81

Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98

Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet (2012) 5.55

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10

The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord (2007) 5.01

Power and predictive accuracy of polygenic risk scores. PLoS Genet (2013) 3.72

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med (2016) 3.68

Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58

Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst (2015) 2.54

Alzheimer's disease genetics: from the bench to the clinic. Neuron (2014) 1.65

Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease. Circulation (2015) 1.63

The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of Life. Ann Intern Med (2015) 1.60

A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry (2015) 1.10

Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat Rev Genet (2016) 1.05

Common polygenic variation enhances risk prediction for Alzheimer's disease. Brain (2015) 1.02

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment. Mol Psychiatry (2016) 0.89

Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach. J Alzheimers Dis (2015) 0.86

Polygenic risk of Alzheimer disease is associated with early- and late-life processes. Neurology (2016) 0.81

Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease. J Alzheimers Dis (2016) 0.81

Defining the Genetic Architecture of Alzheimer's Disease: Where Next. Neurodegener Dis (2015) 0.80

Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease. BMC Neurol (2015) 0.80

Articles by these authors

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. PLoS One (2014) 1.11

Intracranial Vessel Wall MRI: Principles and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol (2016) 0.92

Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. Elife (2016) 0.79

An Empirical Bayes Mixture Model for Effect Size Distributions in Genome-Wide Association Studies. PLoS Genet (2015) 0.78

Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure. PLoS Genet (2016) 0.76

Microstructure of the Default Mode Network in Preterm Infants. AJNR Am J Neuroradiol (2016) 0.75

Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. AJNR Am J Neuroradiol (2017) 0.75

Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study. PLoS Med (2017) 0.75

BKCa channel regulates calcium oscillations induced by alpha-2-macroglobulin in human myometrial smooth muscle cells. Proc Natl Acad Sci U S A (2016) 0.75

Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol (2017) 0.75

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study. PLoS Med (2017) 0.75

Long-Term Effectiveness of Direct CT-Guided Aspiration and Fenestration of Symptomatic Lumbar Facet Synovial Cysts. AJNR Am J Neuroradiol (2017) 0.75

Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma. AJNR Am J Neuroradiol (2017) 0.75